MADRIGAL PHARMACEUTICALS, INC.·4

Jan 20, 5:31 PM ET

Thakkar Rita 4

4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Jan 20, 2026

Insider Transaction Report

Form 4
Period: 2026-01-15
Thakkar Rita
Chief Accounting Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-01-15+2,3982,398 total
  • Award

    Stock Option (Right to Buy)

    [F2]
    2026-01-15+1,8261,826 total
    Exercise: $495.88Exp: 2036-01-15Common Stock (1,826 underlying)
Footnotes (2)
  • [F1]Represents a grant of restricted stock units, which vest as to 25% of the shares on each of January 15, 2027, January 15, 2028, January 15, 2029 and January 15, 2030, provided the Reporting Person continues in service with the Issuer on each such date.
  • [F2]The option vests as to 25% of the shares on the first anniversary of the date of grant (January 15, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
Signature
/s/ Mardi Dier, as Attorney-in-Fact|2026-01-20

Documents

1 file
  • 4
    wk-form4_1768948272.xmlPrimary

    FORM 4